Clinical Trial Update: Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed that compared two post-exposure prophylaxis regimens for HIV infection: FOVIR with emtricitabine plus lopinavir/ritonavir ver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine (Emtricitabine)
• FOVIR
• Lopinavir/ritonavir (lopinavir/ritonavir)
• Maraviroc (maraviroc)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infection | Phase 4 | Status: COMPLETED